FdaApplication
ANDA 206055
Identifiers
- fda_app_no: ANDA206055
Properties
| Property | Value |
|---|---|
| applicant_name | ZYDUS PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2023-06-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
2 products